Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Biologicals")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 889571

  • Page / 35583
Export

Selection :

  • and

Biosimilars ― Science, status, and strategic perspectiveKRESSE, Georg-Burkhard.European journal of pharmaceutics and biopharmaceutics. 2009, Vol 72, Num 3, pp 479-486, issn 0939-6411, 8 p.Article

Opinion on adventitious agents testing for vaccines: Why do we worry so much about adventitious agents in vaccines?SHEETS, Rebecca L.Vaccine. 2013, Vol 31, Num 26, pp 2791-2795, issn 0264-410X, 5 p.Article

Scope and practicality of in vivo testing for adventitious agentsWHITEMAN, M. D.Developments in biologicals. 2006, Vol 123, pp 147-152, issn 1424-6074, 6 p.Conference Paper

Biological treatment in rheumatic diseases: results from a longitudinal surveillance : adverse eventsKONTTINEN, L; HONKANEN, V; NORDSTROM, D. C et al.Rheumatology international (Berlin. Print). 2006, Vol 26, Num 10, pp 916-922, issn 0172-8172, 7 p.Article

Progress in applying the Three Rs of Russell & Burch to the testing of biological productsBALLS, M; HALDER, M.Developments in biologicals. 2002, Vol 111, pp 3-13, issn 1424-6074, 11 p.Conference Paper

Cytokine-based immunointervention in the treatment of autoimmune diseasesADORINI, L.Clinical and experimental immunology (Print). 2003, Vol 132, Num 2, pp 185-192, issn 0009-9104, 8 p.Article

Versorgung mit TNF-α-Blockern und regionale Unterschiede im Jahr 2010 = Prescription of TNF-alpha inhibitors and regional differences in 2010WINDT, R; GLAESKE, G; HOFFMANN, F et al.Zeitschrift für Rheumatologie (Print). 2011, Vol 70, Num 10, issn 0340-1855, 874-881 [7 p.]Article

Biologika bei der Therapie der SoJIA (Morbus Still) : Pädiatrische Rheumatologie = Biologicals in the treatment of SoJIA : Pediatric rheumatologyDÜCKERS, G; NIEHUES, T.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 6, issn 0340-1855, 505-515 [10 p.]Article

Industry perspective for biotech productsMÖRITZ, A.Developments in biologicals. 2004, Vol 118, pp 37-44, issn 1424-6074, 8 p.Conference Paper

An overview of quantitative PCR assays for biologicals: Quality and safety evaluationXU, Y; BRORSON, K.Developments in biologicals. 2003, Vol 113, pp 89-98, issn 1424-6074, 10 p.Conference Paper

ECVAM's activities on biologicalsHALDER, Marlies; BALLS, Michael; HENDRIKSEN, Coenraad et al.ATLA. Alternatives to laboratory animals. 2002, Vol 30, pp 125-128, issn 0261-1929, 4 p., SUP2Conference Paper

Erfolgreiche Therapie mit Etanercept bei rezidivierender Polychondritis = Successful therapy with etanercept in relapsing polychondritisSCHRÄDER, C; LOHMANN, J.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 4, issn 0340-1855, 356-358 [3 p.]Article

Successful Treatment of Recalcitrant Palmoplantar Pustular Psoriasis with Sequential Use of Infliximab and AdalimumabYAWALKAR, Nikhil; HUNGER, Robert E.Dermatology (Basel). 2009, Vol 218, Num 1, pp 79-83, issn 1018-8665, 5 p.Article

Shifting paradigms: biopharmaceuticals versus low molecular weight drugsCROMMELIN, Daan J. A; STORM, Gert; VERRIJK, Ruud et al.International journal of pharmaceutics. 2003, Vol 266, Num 1-2, pp 3-16, issn 0378-5173, 14 p.Article

Implementation of Three Rs alternatives in regulatory testing: Possibilities and obstacles: the view of the validatorHALDER, M; BALLS, M.Developments in biologicals. 2002, Vol 111, pp 199-206, issn 1424-6074, 8 p.Conference Paper

Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab)HEILIGENHAUS, Arnd; MISEROCCHI, Elisabetta; HEINZ, Carsten et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 8, pp 1390-1394, issn 1462-0324, 5 p.Article

Biologicals dramatic advances in the treatment of psoriasisWILSMANN-THEIS, Dagmar; MARTIN, Saskia; REBER, Michael et al.Current pharmaceutical design. 2006, Vol 12, Num 8, pp 989-999, issn 1381-6128, 11 p.Article

Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experienceNORDSTRÖM, D. C; KONTTINEN, L; HONKANEN, V et al.Rheumatology international (Berlin. Print). 2006, Vol 26, Num 8, pp 741-748, issn 0172-8172, 8 p.Article

Profiling lymphocyte subpopulations in peripheral blood under efalizumab treatment of psoriasis by multi epitope ligand cartography (MELC) robot microscopyBONNEKON, Bernd; MALYKH, Yanina; BÖCKELMANN, Raik et al.EJD. European journal of dermatology. 2006, Vol 16, Num 6, pp 623-635, issn 1167-1122, 13 p.Article

Neue Entwicklungen in der systemischen Psoriasistherapie = Novel developments in the systemic treatment of psoriasisFRIEDRICH, Markus; STERRY, Wolfram; ASADULLAH, Khusru et al.Journal der Deutschen Dermatologischen Gesellschaft (Print). 2003, Vol 1, Num 1, pp 12-21, issn 1610-0379, 10 p.Article

Synovektomie der grossen Gelenke in der Ära der Biologika : Elektive Rheumachirurgie aus Sicht des Rheumaorthopäden und internistischen Rheumatologen = Large-joint synovectomy in the era of biological therapies : Elective rheumatological surgery from the perspective of rheumatoid orthopedists and internist rheumatologistsCARL, H.-D; RECH, J.Zeitschrift für Rheumatologie (Print). 2011, Vol 70, Num 1, issn 0340-1855, 9-13 [4 p.]Article

Optimal care for early RA patients: the challenge of translating scientific data into clinical practiceVERSCHUEREN, Patrick; WESTHOVENS, René.Rheumatology (Oxford. Print). 2011, Vol 50, Num 7, pp 1194-1200, issn 1462-0324, 7 p.Article

Biological Therapy for Pediatric Malignancy : Current Perspectives : Advances in therapyAGARWAL, Bharat.Indian journal of pediatrics. 2008, Vol 75, Num 8, pp 839-844, issn 0019-5456, 6 p.Article

Cost-effectiveness of infliximab in the treatment of rheumatoid arthritis in clinical practiceVIRKKI, L. M; KONTTINEN, Y. T; HEIKKILÄ, S et al.Clinical and experimental rheumatology (Testo stampato). 2008, Vol 26, Num 6, pp 1059-1066, issn 0392-856X, 8 p.Article

Indikation und Option neuer immunmodulatorischer Therapien beim Sjögren-Syndrom : Moderne Therapie der Kollagenosen = Indications and options of new immune modulatory therapies for Sjögren's syndromeFEIST, E; DÖRNER, T; HANSEN, A et al.Zeitschrift für Rheumatologie (Print). 2007, Vol 66, Num 8, pp 679-685, issn 0340-1855, 7 p.Article

  • Page / 35583